Anke Van Lierop
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 5
- Cancer-related Molecular Pathways 2
- HER2/EGFR in Cancer Research 2
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- H. Bier (5 shared papers)Thomas K. Hoffmann (4 shared papers)I. Haas (1 shared paper)Vera Balz (3 shared papers)U. Häuser (3 shared papers)Reidar Grénman (2 shared papers)Kathrin Scheckenbach (2 shared papers)Thomas E. Carey (1 shared paper)
- Journals
- Oral Oncology (2 papers)Journal of Investigative Dermatology (2 papers)British Journal of Dermatology (1 paper)Biology of Reproduction (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- GermanyUnited StatesHungary
In The Last Decade
Anke Van Lierop
9 papers receiving 235 citations
Peers
Comparison fields: 5 of 49
- Otorhinolaryngology 42
- Oncology 109
- Cancer Research 23
- Immunology 30
- Molecular Biology 65
Countries citing papers authored by Anke Van Lierop
This map shows the geographic impact of Anke Van Lierop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Van Lierop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Van Lierop more than expected).
Fields of papers citing papers by Anke Van Lierop
This network shows the impact of papers produced by Anke Van Lierop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Van Lierop. The network helps show where Anke Van Lierop may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Van Lierop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 78 | |
| 2 | 2008 | 50 | |
| 3 | 2002 | 43 | |
| 4 | 2001 | 25 | |
| 5 | 2020 | 15 | |
| 6 | 2022 | 13 | |
| 7 | 2002 | 11 | |
| 8 | 2025 | 1 | |
| 9 | 2019 | 1 |
About Anke Van Lierop
Anke Van Lierop is a scholar working on Oncology, Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology, having authored 9 papers that have together received 237 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (2 papers), Cancer-related Molecular Pathways (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (1 paper), Head and Neck Cancer Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Acne and Rosacea Treatments and Effects (1 paper). The work is most often cited by research in Otorhinolaryngology (42 citations), Oncology (109 citations), Cancer Research (23 citations), Immunology (30 citations) and Molecular Biology (65 citations). Anke Van Lierop has collaborated with scholars based in Germany, United States and Hungary. Frequent co-authors include H. Bier, Thomas K. Hoffmann, I. Haas, Vera Balz, U. Häuser, Reidar Grénman, Kathrin Scheckenbach, Thomas E. Carey, U Friebe-Hoffmann and Martin Wagenmann. Their work appears in journals such as Oral Oncology, Journal of Investigative Dermatology, British Journal of Dermatology, Biology of Reproduction and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.